Advertisement
U.S. markets closed

Mersana Therapeutics, Inc. (MRSN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.8600-0.1800 (-3.57%)
At close: 04:00PM EDT
4.8600 0.00 (0.00%)
After hours: 05:39PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 3/18/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
607.12M279.75M153.04M396.31M448.24M584.67M
Enterprise Value
431.67M73.11M-98.51M158.07M203.83M331.39M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
15.776.323.4610.2314.4842.51
Price/Book (mrq)
16.455.361.706.164.876.83
Enterprise Value/Revenue
11.716.83-12.8014.8426.1322.56
Enterprise Value/EBITDA
-2.60-4.052.45-2.98-3.72-7.59

Trading Information

Stock Price History

Beta (5Y Monthly) 1.51
52-Week Change 38.24%
S&P500 52-Week Change 328.64%
52 Week High 39.6200
52 Week Low 30.8010
50-Day Moving Average 33.9791
200-Day Moving Average 32.7508

Share Statistics

Avg Vol (3 month) 32.29M
Avg Vol (10 day) 33.18M
Shares Outstanding 5121.3M
Implied Shares Outstanding 6121.3M
Float 864.31M
% Held by Insiders 11.33%
% Held by Institutions 195.90%
Shares Short (Feb 29, 2024) 47.14M
Short Ratio (Feb 29, 2024) 43.08
Short % of Float (Feb 29, 2024) 46.41%
Short % of Shares Outstanding (Feb 29, 2024) 45.89%
Shares Short (prior month Jan 31, 2024) 46.65M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-195.57%

Management Effectiveness

Return on Assets (ttm)-38.13%
Return on Equity (ttm)-266.24%

Income Statement

Revenue (ttm)36.85M
Revenue Per Share (ttm)0.32
Quarterly Revenue Growth (yoy)-27.10%
Gross Profit (ttm)N/A
EBITDA -169.44M
Net Income Avi to Common (ttm)-171.67M
Diluted EPS (ttm)-1.4800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)209.08M
Total Cash Per Share (mrq)1.72
Total Debt (mrq)33.83M
Total Debt/Equity (mrq)91.67%
Current Ratio (mrq)3.36
Book Value Per Share (mrq)0.31

Cash Flow Statement

Operating Cash Flow (ttm)-168.88M
Levered Free Cash Flow (ttm)-85.71M